The science behind the platform, made readable.
A scientific content library on growth factors, oleosomes, biotech skincare actives, formulation, and clinical evidence. Written for formulators, R&D teams, and brand leaders evaluating the next generation of topical actives.
EGF vs. FGF-2 in skincare: which growth factor does what?
A side-by-side breakdown of the two most studied recombinant growth factors in topical skincare, what each one does at a cellular level, where each one shines clinically, and how to choose between them (or combine them).
Read article →Growth factors vs. retinol: which one actually works better?
Retinol is the gold standard. Recombinant growth factors are the challenger. We compare head-to-head clinical data, mechanism, tolerance, and where each ingredient genuinely outperforms the other.
Read article →Do oleosomes actually help proteins penetrate the skin?
Oleosomes are native plant lipid droplets being used as biomimetic carriers for large active proteins. Here is what the data shows about how, and how deep, oleosome-fused actives reach into skin and scalp.
Read article →Are growth factors stable in cosmetic formulations?
Stability depends on pH, temperature, preservatives, processing, packaging, and delivery system. A practical guide for skincare brands evaluating growth factor ingredients before commercial launch.
Read article →Can growth factors penetrate the skin?
Growth factors are large proteins, so topical penetration depends on barrier condition, formulation design, and the carrier system. Why delivery technology is part of the active, not an afterthought.
Read article →What are oleosomes in skincare?
Definition, structure, brand relevance, and how oleosomes compare to liposomes and emulsions as biomimetic delivery systems for biotech actives.
Read article →Plant-made growth factors: the future of biotech skincare ingredients?
Plant-made recombinant proteins compared to microbial and animal-cell production. Scalability, sustainability, INCI strategy, and limitations for skincare brands.
Read article →Growth factors vs. peptides in skincare: which should brands choose?
Peptides are easier to formulate. Growth factors signal through full receptors. We compare size, stability, evidence, and brand fit so R&D teams can choose, or combine, the right active.
Read article →Retinol alternatives for skincare brands.
Growth factors, peptides, exosomes, bakuchiol, niacinamide, PDRN, ectoin, and barrier actives. The best retinol alternative depends entirely on which outcome and which user you are designing for.
Read article →How to formulate with growth factors in skincare products.
A practical formulator checklist: pH, temperature, preservatives, processing, packaging, dosage, and stability testing. Built for cosmetic R&D and CDMOs.
Read article →EGF in skincare: benefits, limits, and formulation challenges.
What recombinant EGF actually does in the epidermis, where it earns its premium position, and why formulation discipline decides whether the molecule still works at end of shelf life.
Read article →FGF-2 in skincare: benefits, limits, and formulation challenges.
FGF-2 is the dermal active. With proper stability and delivery, it supports defensible premium anti-aging positioning. Without them, it is an expensive label on an INCI list.
Read article →Best biotech active ingredients for anti-aging skincare brands.
A shortlist of recombinant growth factors, signaling peptides, exosome-inspired technologies, PDRN, fermented actives, ectoin, enzymes, and the delivery systems that make them functional.
Read article →Exosomes vs. growth factors in skincare: what brands should know.
Exosomes and growth factors compared on definition, standardization, evidence depth, and regulatory exposure. Why defined actives are usually easier for B2B evaluation.
Read article →What is the best delivery system for growth factors in skincare?
Liposomes, polymeric nanoparticles, hydrogels, microemulsions, oleosomes. How each carrier interacts with sensitive proteins, and where oleosome-based delivery has structural advantages.
Read article →How skincare brands should evaluate a growth factor ingredient supplier.
A practical checklist for R&D and procurement: identity, purity, stability, delivery, evidence, regulatory documentation, manufacturing consistency, and technical support.
Read article →Growth factors for sensitive skin: retinol-like results without irritation?
How to position growth factors for sensitive-skin premium anti-aging: gentle formulation, barrier-friendly co-actives, finished-product tolerance data, and conservative claim strategy.
Read article →The future of anti-aging skincare: from retinoids to biotech actives.
How biotech actives, ambient-stable delivery, and tighter clinical methodology are reshaping premium product strategy. What brands should build now.
Read article →